Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1000 of 1048 entries
View as:

SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Phase: N/A Priority: Normal
NCT ID: NCT06020066 Org: User:
Start: 08/10/23 End: 08/10/29 Due: 08/10/30

Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy

Phase: N/A Priority: Normal
NCT ID: NCT03659292 Org: User:
Start: 09/30/18 End: 10/31/22 Due: 10/31/23

Anatomical Resection VS. Nonanatomical Resection for Colorectal Liver Metastases With Gene Mutation or Right-sidedness

Phase: N/A Priority: Normal
NCT ID: NCT05881746 Org: User:
Start: 07/01/23 End: 07/01/28 Due: 07/01/29

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06970353 Org: User:
Start: 06/01/25 End: 12/30/31 Due: 12/30/32

Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05057845 Org: User:
Start: 09/26/21 End: 09/20/26 Due: 09/20/27

Reverse Triple Negative Immune Resistant Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05076682 Org: User:
Start: 06/30/22 End: 03/31/23 Due: 03/31/24

A Prospective Clinical Study for Laparoscopic D3 Dissection With Preservation of Left Colic Artery in Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02753465 Org: User:
Start: 04/30/16 End: 12/31/19 Due: 12/31/20

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06404463 Org: User:
Start: 05/06/24 End: 11/06/30 Due: 11/06/31

Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined with Local Treatment in Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06856187 Org: User:
Start: 02/28/25 End: 04/30/27 Due: 04/30/28

Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06519526 Org: User:
Start: 08/12/24 End: 08/31/27 Due: 08/31/28

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Phase: N/A Priority: Normal
NCT ID: NCT04492969 Org: User:
Start: 09/01/20 End: 08/31/25 Due: 08/31/26

Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase

Phase: N/A Priority: Normal
NCT ID: NCT01715532 Org: User:
Start: 07/31/12 End: 06/30/16 Due: 06/30/17

Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06344793 Org: User:
Start: 05/20/23 End: 02/01/25 Due: 02/01/26

The Value of ctDNA on Chemotherapy Efficacy for mCRC

Phase: N/A Priority: Normal
NCT ID: NCT04555369 Org: User:
Start: 09/23/20 End: 09/01/25 Due: 09/01/26

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00933673 Org: User:
Start: 06/30/09 End: 06/30/12 Due: 06/30/13

Predictive Value of Intraoperative Indocyanine Green Clearance Test After Partially Blood Flow Blocking in Postoperative Liver Reserve

Phase: N/A Priority: Normal
NCT ID: NCT03654183 Org: User:
Start: 09/01/17 End: 08/31/19 Due: 08/31/20

Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）

Phase: N/A Priority: Normal
NCT ID: NCT05781074 Org: User:
Start: 03/23/23 End: 12/30/25 Due: 12/30/26

Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04025164 Org: User:
Start: 07/01/18 End: 06/30/28 Due: 06/30/29

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03241914 Org: User:
Start: 07/04/17 End: 06/18/20 Due: 06/18/21

Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail

Phase: N/A Priority: Normal
NCT ID: NCT02117895 Org: User:
Start: 01/31/14 End: 01/31/17 Due: 01/31/18

Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04281641 Org: User:
Start: 04/21/20 End: 04/30/30 Due: 04/30/31

Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05201430 Org: User:
Start: 08/27/21 End: 07/31/27 Due: 07/31/28

An Observational Study for Gastric Cancer in Asymptomatic Carriers of High Risk Helicobacter Pylori

Phase: N/A Priority: Normal
NCT ID: NCT06896370 Org: User:
Start: 05/01/25 End: 12/31/35 Due: 12/31/36

Effects of Fish Oil in Alleviating Health Hazards Associated With Ozone Exposure

Phase: N/A Priority: Normal
NCT ID: NCT03697499 Org: User:
Start: 09/20/18 End: 12/30/19 Due: 12/30/20

Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06797622 Org: User:
Start: 02/15/25 End: 04/15/27 Due: 04/15/28